According to Cocrystal Pharma 's latest financial reports the company's current earnings (TTM) are -$21.24 M. a decrease over its 2022 earnings that were of -$18.14 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$21.24 M | 17.09% |
2022 | -$18.14 M | 27.9% |
2021 | -$14.19 M | 47.11% |
2020 | -$9.64 M | -79.98% |
2019 | -$48.15 M | -22.92% |
2018 | -$62.47 M | 651.62% |
2017 | -$8.32 M | -92.14% |
2016 | -$0.11 B | 96.12% |
2015 | -$53.95 M | 830.46% |
2014 | -$5.8 M | 18.04% |
2013 | -$4.92 M | 95.95% |
2012 | -$2.51 M | -31.98% |
2011 | -$3.69 M | |
2009 | -$0.05 M | -23.29% |
2008 | -$0.06 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $16.97 B | -80,017.13% | ๐บ๐ธ USA |
Merck MRK | $3.03 B | -14,391.10% | ๐บ๐ธ USA |
Nature's Sunshine Products NATR | $20.27 M | -195.45% | ๐บ๐ธ USA |
USANA USNA | $0.10 B | -583.66% | ๐บ๐ธ USA |